ACMG Applauds Investment in Precision/Personalized Medicine
President Obama rolled out a plan on Jan. 30, 2015 to invest $215 million in "precision medicine". ACMG applauds this investment in genomic medicine and we look forward to providing input into the process moving forward as leaders in advancing the field of genetics and genomics into all of healthcare. President Obama said that precision or personalized medicine "gives us one of the greatest opportunities for new medical breakthroughs that we have ever seen." ACMG is already actively developing the standards by which genomic medicine will be practiced including practice guidelines for laboratories and clinicians and is partnered in the Clinical Genomics Resource (ClinGen) Project that is bringing the expertise of those trained in this field to the clinical curation of genomic variation based on data provided by clinical genetics and genomics service providers across the country. Read more about President Obama's Precision Medicine Initiative here.
ACMG thanks its members, Board and staff who work tirelessly on behalf of patients and families every day to make the promise of genomic medicine a reality in improving public health and in preventing and treating genetic diseases.
You can watch the White House video here on the Precision Medicine Initiative - note the actual press conference starts at around the 22:00 minute mark.
There has never been a more exciting time to be involved in genetic medicine and ACMG certainly will continue to play an important role in translating genetic discoveries into better patient care.
ACMG Releases Member Survey Results on Secondary Findings and Reinforces Earlier Recommendations in New Policy Statement on Secondary Findings
The American College of Medical Genetics and Genomics (ACMG) has released two documents "online ahead of print" in its peer-reviewed academic journal, Genetics in Medicine:
1. "American College of Medical Genetics and Genomics (ACMG) Policy Statement: Updated Recommendations Regarding Analysis and Reporting of Secondary Findings in Clinical Genome-Scale Sequencing"
2. "Reporting Genomic Secondary Findings: ACMG Members Weigh In".
Click here to access news release